EUVIMEDEUVIMED entdecken
Crossref

Ganoderma lucidum ethanol extracts ameliorate hepatic fibrosis and promote the communication between metabolites and gut microbiota g_Ruminococcus through the NF-κB and TGF-β1/Smads pathways

Jing Zhang, Wen Wang, Xinge Cui, Pengling Zhu, Siyu Li, Shujie Yuan, Daiyin Peng, Can Peng

Journal of Ethnopharmacology · 2024

DOI: 10.1016/j.jep.2023.117656 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Ethnopharmacology, 2024. Verfasst von Jing Zhang und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Anhui University of Chinese Medicine, Hefei, 230012, China; Center for Xin'an Medicine and Modernization of Traditional Chinese M…. Hauptthemen laut MEDLINE: Reishi, Gastrointestinal Microbiome. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 72 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

ETHNOPHARMACOLOGICAL RELEVANCE: Ganoderma lucidum, a traditional edible medicinal mushroom, has been widely reported to improve liver diseases as a dietary intervention for people. Ganoderma lucidum extracts, primarily total triterpenoids (GLTTs), are one of the bioactive ingredients that have excellent beneficial effects on hepatic fibrosis. Therefore, its prevention and reversal are particularly critical due to the increasing number of patients with chronic liver diseases worldwide. AIM OF THE STUDY: The study aimed to evaluate whether GLTTs had a hepatoprotective effect against hepatic fibrosis through metabolic perturbations and gut microbiota changes and its underlying mechanisms. MATERIALS AND METHODS: The compound compositions of GLTTs were quantified, and carbon tetrachloride (CCl4)-induced hepatic fibrosis rats were used to investigate the cause of the improvement in various physiological states with GLTTs treatment, and to determine whether its consequent effect was associated with endogenous metabolites and gut microbiota using UPLC-Q-TOF-MSE metabolomics and 16S rRNA gene sequencing technology. RESULTS: GLTTs alleviated physical status, reduced liver pathological indicators, proinflammatory cytokines, and deposition of hepatic collagen fibers via regulating the NF-κB and TGF-β1/Smads pathways. The untargeted metabolomics analysis identified 16 potential metabolites that may be the most relevant metabolites for gut microbiota dysbiosis and the therapeutic effects of GLTTs in hepatic fibrosis. Besides, although GLTTs did not significantly affect the α-diversity indexes, significant changes were observed in the composition of microflora structure. In addition, Spearman analysis revealed strong correlations between endogenous metabolites and gut microbiota g_Ruminococcus with hepatic fibrosis. CONCLUSION: GLTTs could provide a potential target for the practical design and application of novel functional food ingredients or drugs in the therapy of hepatic fibrosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ReishiGastrointestinal MicrobiomeHumansRatsAnimalsNF-kappa BTransforming Growth Factor beta1RuminococcusRNA, Ribosomal, 16SLiver CirrhosisCommunicationCarbon Tetrachloride

Stichwörter der Autor:innen

Ganoderma lucidum ethanol extractsGut microbiotaHepatic fibrosisNF-κB and TGF-β1/Smads pathwaysUntargeted metabolomicsg_Ruminococcus

Substanzen

NF-kappa BTransforming Growth Factor beta1RNA, Ribosomal, 16SCarbon Tetrachloride

Autor:innen und Institutionen

  • School of Pharmacy, Anhui University of Chinese Medicine, Hefei, 230012, China; Center for Xin'an Medicine and Modernization of Traditional Chinese Medicine of IHM, Anhui University of Chinese Medicine, Hefei, 230012, C…
  • School of Pharmacy, Anhui University of Chinese Medicine, Hefei, 230012, China; Anhui Province Key Laboratory of Pharmaceutical Preparation Technology and Application, Hefei, Anhui, 230012, China; Center for Xin'an Medi…
  • School of Pharmacy, Anhui University of Chinese Medicine, Hefei, 230012, China; Generic Technology Research Center for Anhui TCM Industry, Anhui University of Chinese Medicine, Hefei, 230012, China; MOE-Anhui Joint Coll…
  • School of Pharmacy, Anhui University of Chinese Medicine, Hefei, 230012, China; Rural Revitalization Collaborative Technical Service Center of Anhui Province, Anhui University of Chinese Medicine, Hefei, 230012, China;…

Zitieren

APA

Zhang, J., Wang, W., Cui, X., Zhu, P., Li, S., Yuan, S., Peng, D., & Peng, C. (2024). Ganoderma lucidum ethanol extracts ameliorate hepatic fibrosis and promote the communication between metabolites and gut microbiota g_Ruminococcus through the NF-κB and TGF-β1/Smads pathways. Journal of Ethnopharmacology. https://doi.org/10.1016/j.jep.2023.117656

Vancouver

Zhang J, Wang W, Cui X, Zhu P, Li S, Yuan S, et al. Ganoderma lucidum ethanol extracts ameliorate hepatic fibrosis and promote the communication between metabolites and gut microbiota g_Ruminococcus through the NF-κB and TGF-β1/Smads pathways. Journal of Ethnopharmacology. 2024. doi:10.1016/j.jep.2023.117656

BibTeX
@article{Zhang2024,
  author = {Zhang, Jing and Wang, Wen and Cui, Xinge and Zhu, Pengling and Li, Siyu and Yuan, Shujie and Peng, Daiyin and Peng, Can},
  title = {Ganoderma lucidum ethanol extracts ameliorate hepatic fibrosis and promote the communication between metabolites and gut microbiota g_Ruminococcus through the NF-κB and TGF-β1/Smads pathways},
  journal = {Journal of Ethnopharmacology},
  year = {2024},
  doi = {10.1016/j.jep.2023.117656}
}
Kostenlos starten →